Home


News Release Archives:

2004 | 2003 | 2002
2001 | 2000 | 1999
1998 | 1997



 

David Brudnoy Fund at MGH receives $400,000 bequest from Brudnoy estate
Unrestricted donation to support MGH AIDS endeavors

BOSTON - December 8, 2005 - The David Brudnoy Fund for AIDS Research at the Massachusetts General Hospital (MGH) has received $400,000 from the estate of David Brudnoy. The well-known and respected Boston radio commentator and talk show host named the fund as a beneficiary of his will. The unrestricted bequest will be presented to the hospital Dec. 9, the first anniversary of Brudnoy's death from cancer.

"David was very committed to helping others with HIV and AIDS," said Ward Cromer, a long-time friend of Brudnoy's and executor of his estate. "He started the Brudnoy Fund in order to support MGH in its efforts to provide flexible and innovative research."

The David Brudnoy Fund for AIDS Research was created by Brudnoy a decade ago following a very public hospitalization during his battle with AIDS. Established to raise private and corporate support for basic and clinical AIDS research at the MGH and the hospital's HIV/AIDS initiatives in Durban, South Africa, this funding is critical to giving MGH researchers the flexibility required to respond to new discoveries and quickly apply them to patient care.

"At the MGH and other leading researcher institutions, efforts to explore exciting new avenues of research are confounded by reductions in traditional sources of funding," says Bruce Walker, MD, director of the Partners AIDS Research Center at the MGH. "Some of our young investigators with innovative approaches find it particularly difficult to get the grants needed to pursue what may turn out to be revolutionary approaches to defeating HIV. The type of funding that the Brudnoy Fund provides allows our investigators to explore projects that otherwise might go without adequate funding."

Several of the projects supported by the fund include the David Brudnoy Innovative Research Fund, which provides rapid support for innovative new research approaches to HIV/AIDS prevention and treatment and vaccines; the creation of the David Brudnoy HIV Scholar Award, presented once a year to provide funding support for promising young AIDS researchers at MGH; and a new program that places MGH residents in Africa at the heart of the epidemic where human and infrastructure resources are stretched beyond the limit, and where these residents serve as mentors, training local physicians, medical students and nurses in optimal medical care, thus playing a pivotal role in building the next generation of AIDS researchers.

"This contribution is a reminder of the continuous support David provided to others," says Cromer. "And it is a challenge to all of us to pick up where he left off." For more information about the David Brudnoy Fund for AIDS Research at the MGH, contact the MGH Development Office at 617-726-2200.

Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $500 million and major research centers in AIDS, cardiovascular research, cancer, cutaneous biology, medical imaging, neurodegenerative disorders, transplantation biology and photomedicine. In 1994, MGH and Brigham and Women's Hospital joined to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups, and nonacute and home health services.

Media Contact: Michelle Marcella, MGH Public Affairs

Physician Referral Service: 1-800-388-4644
Information about Clinical Trials